The Asia-Pacific Animal Health market is estimated to grow at a CAGR of 5.7% during the forecast period to reach USD 20.25 Billion by 2021. Factors such as the rapid rise in livestock population, increasing awareness about animal health, growing demand for animal-derived food products, and rising frequency of animal disease outbreaks are the major factors driving the growth of the Asia-Pacific Animal Health market. However, restrictions on the use of parasiticides in food-producing animals, rising storage cost of animal vaccines, and the shift towards vegetarian diets are restraining the growth of this market to a certain extent.

In this report, the market is segmented on the basis of product, type of animal, and country. Based on product, the market is segmented into growth promoters, feed additives, vaccines, parasiticides, antimicrobials and antibiotics, and other pharmaceuticals. Growth promoters accounted for the largest share of the market in 2015 owing to its wide utilization by livestock producers and pet owners. Based on the type of animal, the market is segmented into food-producing animals and companion animals. The food-producing animals segment accounted for the largest share of the market, while companion animals are expected to register the highest growth during the forecast period.

Geographically, the Asia-Pacific Animal Health market is segmented into China, Japan, India, and the Rest of APAC. In 2015, China commanded a major share of the market and is expected to witness the highest growth rate during the forecast period. Growth in the Chinese animal health market can be attributed to the growing livestock population, increasing consumption of animal-derived food products, growing awareness about animal health and zoonotic diseases, and rising frequency of animal disease outbreaks in China.

Some of the prominent players in the market include Zoetis, Inc. (U.S.), Sanofi (France), Eli Lilly and Company (U.S.), Merck and Co., Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim GmbH (Germany), Ceva Sant� Animale (France), Virbac (France), Vetoquinol S.A. (France), and Cargill, Inc. (U.S.).

Target Audience:

Veterinary pharmaceutical manufacturers

Veterinary feed manufacturers

Animal health centers

Animal health research and development (R&D) companies

Government associations

Market research and consulting firms

Venture capitalists and investors

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

The research report categorizes the Asia-Pacific Animal Health market into the following segments and subsegments:

Asia-Pacific Animal Health Market, by Product

Growth Promoters Antibiotic Growth Promoters Hormonal Growth Promoters Feed Enzyme Growth Promoters Beta Agonist Growth Promoters Prebiotics and Probiotics Phytogenics Other Growth Promoters

Feed Additives/Nutritional Products Amino Acids Binders Vitamins Minerals Feed Acidifiers Antioxidants Other Feed Additives/Nutritional Products

Vitamins Live Attenuated Vaccines Inactivated Vaccines Toxoid Vaccines Recombinant Vaccines Conjugate Vaccines Subunit Vaccines

Parasiticides Ectoparasiticides Pour-ons and Spot-ons Sprays Dips Ear-tags Collars Oral Tablets Other Ectoparasiticides Endoparasiticides Oral Liquids Oral Solids Injectables Feed Additives Other Ectoparasiticides Endectocides

Antimicrobials and Antibiotics Cephalosporins Penicillins Tetracyclines Macrolides Aminoglycosides Sulfonamides Other Antimicrobials and Antibiotics

Other Pharmaceuticals

Asia-Pacific Animal Health Market, by Type of Animal

Food-producing Animals

Companion Animals

Asia-Pacific Animal Health Market, by Country

China

Japan

India

Rest of Asia-Pacific (Rest of APAC)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company�s specific needs. The following customization options are available for the report:

Product Analysis

Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis

Further breakdown of the Rest of Asia-Pacific animal health market into Australia, New Zealand, Vietnam, and others

Company Information

Detailed analysis and profiling of additional market players (Up to 5)

The Asia-Pacific Animal Health market is expected grow significantly in the coming years. Increasing livestock population, growing awareness about animal health, rising demand for animal-derived food products, and rising frequency of animal disease outbreaks are some the major factors driving the growth of the Asia-Pacific Animal Health market. The market is projected to reach to USD 20.25 Billion by 2021 from USD 15.32 Billion in 2016, at a CAGR of 5.7% during the forecast period. However, restrictions on the use of parasiticides in food-producing animals, the shift towards vegetarian diets, and rising storage costs for animal vaccines are restraining the growth of the market.

In this report, the APAC animal health market is segmented based on product, type of animal, and country. Based on product, the market is segmented into growth promoters, feed additives, parasiticides, vaccines, antimicrobials and antibiotics, and other pharmaceuticals. The growth promoters segment accounted for the largest share of the market owing to its wide utilization by livestock producers and pet owners. Based on type of animal, the market is segmented into food-producing animals and companion animals. The food-producing animals segment held the largest share of the Asia-Pacific Animal Health market, while the companion animals segment is expected to witness the highest growth during the forecast period.

In 2015, China dominated the Asia-Pacific Animal Health market followed by Japan, India, and the Rest of APAC. Factors such as the huge pool of food-producing animals, growing demand for animal-derived food products, and frequent occurrence of animal diseases are driving the growth of the market. China is expected to register the highest growth during the forecast period followed by India and Japan.

The APAC animal health market is characterized by the presence of a large number of players. Amidst intense market competition, major players are continuously focusing on achieving higher market shares through new product launches and mergers & acquisitions of local as well as multinational players in the market. The market is fragmented in nature, with a large number of companies continuously trying to mark their presence. Major players operating in this market include Zoetis, Inc. (U.S.), Eli Lilly and Company (U.S.), Sanofi (France), Merck and Co., Inc. (U.S.), Boehringer Ingelheim GmbH (Germany), Bayer AG (Germany), Virbac (France), Ceva Sant� Animale (France), Vetoquinol S.A. (France), Cargill, Inc. (U.S.), Royal DSM N.V. (Netherlands), and Perrigo Company Plc (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst